Hostname: page-component-7479d7b7d-c9gpj Total loading time: 0 Render date: 2024-07-10T21:45:55.591Z Has data issue: false hasContentIssue false

P-268 - Combined Metabolic and Psychological Screening for Mood Disorders in Children With Type 1 Diabetes

Published online by Cambridge University Press:  15 April 2020

A. Butwicka
Affiliation:
Department of Child Psychiatry, Medical University of Warsaw, Warsaw, Poland
W. Fendler
Affiliation:
Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland
A. Zalepa
Affiliation:
Warsaw School of Social Science and Humanities, Warsaw, Lodz, Poland
A. Szadkowska
Affiliation:
Department of Pediatrics, Oncology, Hematology and Diabetology, Lodz, Poland
B. Mianowska
Affiliation:
Department of Pediatrics, Oncology, Hematology and Diabetology, Lodz, Poland
A. Gmitrowicz
Affiliation:
Department of Adolescent Psychiatry, Medical University of Lodz, Lodz, Poland
W. Młynarski
Affiliation:
Department of Pediatrics, Oncology, Hematology and Diabetology, Lodz, Poland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives:

To compare the diagnostic accuracy and cost-effectiveness of screening models based on glycated hemoglobin level (HbA1c) and psychometric measures in detecting mood disorders among children with type 1 diabetes (T1DM)

Methods:

A random sample of 26% out of 632 available subjects aged 8–18 years with T1DM lasting longer than 12 months were enrolled to the study. All subjects were tested using a semi-structured clinical interview (KSADS-PL, duration = 120 mins/patient) as a standard of reference for the diagnosis of major depression disorders (MDD) and mood disorders (MD). Four screening approaches evaluated by the authors were: 1- Children Depression Inventory (CDI, duration = 30 mins/patient); 2- centile of HbA1c; 3- centile of HbA1c with CDI; 4- centile of HbA1c with Children's Depression Rating Scale (CDRS duration=40 mins/patient). All tests were performed in all individuals and cost-effectiveness of all 4 approaches was calculated as total time needed to successfully detect one case of MD or MDD.

Results:

The HbA1c+CDRS model was the best screening procedure for both MD and MDD. Diagnostic threshold for HbA1c was established at 93rd percentile (8.7%) for MD and 95th (9.0%) for MDD. Cut-off points for CDRS assessed after filtering by HbA1c percentile equaled 26 (MD) and 30 (MDD) points. Application of this procedure would result in a 76% workload reduction for one diagnosed patient with MD and 83% with MDD in comparison to standard screening with CDI.

Conclusions:

Centile of HbA1c level with subsequent examination with CDRS is cost-effective procedure for screening individuals with T1D prior to psychiatric.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.